AEON Biopharma, Inc.
AEON0.27003.23% ( -0.0090 )
Current ValuationThe current P/E ratio is -0.25, within the reasonable range, cheaper than 40.66% of the time in the past 3 years, and the industry ranks 110/602, the industry Median -2.11.
-0.247xP/E
$0.27Stock price
$-1.10Earnings per share
-0.247xP/E
Stock price$0.27Earnings per share$-1.10
Historical Valuation
P/E ratioTypical rangeMedian
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
019385776
The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.